Press Releases

Press Releases

May 08, 2019
Twist Bioscience Announces Pricing of $78.8 Million Public Offering of Common Stock
May 06, 2019
Twist Bioscience Announces Proposed Public Offering of Common Stock
Apr 30, 2019
Twist Bioscience Reports Second Quarter Fiscal 2019 Financial Results and Highlights Commercial and Operational Progress
Apr 25, 2019
Twist Bioscience Announces Synthetic DNA Biosecurity Publication in Frontiers
Apr 18, 2019
Twist Bioscience to Report Fiscal 2019 Second Quarter Financial Results on Tuesday, April 30, 2019
Apr 15, 2019
Twist Bioscience and iGEM Partner to Provide Synthetic DNA for iGEM Competition and Registry
Apr 11, 2019
Twist Bioscience Announces Antibody Optimization Agreement with Pandion Therapeutics
Apr 09, 2019
Twist Bioscience Customized Libraries for Biologics Discovery Highlighted at PEGS Boston 2019
Apr 09, 2019
Twist Bioscience Adopts Battelle’s ThreatSEQ™ DNA Screening Web Service for Advanced Biosecurity
Apr 04, 2019
Twist Bioscience and LakePharma Form Strategic Collaboration to Provide Antibody Discovery and Development Services